Member Info for havealot

In my experience share are often bought back as an alternative to paying out dividends, capital gains less of a tax liability to directors owning vast numbers of shares. Or am I being synical.

What you say is correct if the shares increase above the average purchase price, but remember many of these share were purchased at much higher price than those purchase recently. Unfortunately most companies seem to buy back their shares when they are near their peak and as a consequence shoot themselves in the foot. This has been a major gripe of mine. Their are two issues namely will the share price recover and will the directors refrain from finding a way of pocketing the shares themselves as as happened recently with this company. Another way of looking at this is Also theoretically
with reduced shares on issue prospective eps should be increasing and this should be relected in the share price.

Hi all. I do not think that I have posted on this board before, I have had little knowledge to impart on the advertising industry. My small shareholding here was obtained on the Autonomy/Blinkx spinoff all those years ago. However I have been a regular reader of this board during those years even though this investment has been a 'bottom draw' job for me. Nevertheless I had hoped to turn a profit someday. I have enjoyed reading all your comments and I thank you all for your efforts.
As for the current situation, I believe that in all my years of investing that I can recall having observed such blatent 'hands in the till' behavour as that recently by the Tremor management. Some time ago I had vowed to avoid in future investing in companies with Isreali management. This is after some experience, recently with Telit and Playtech. I do not believe the moral standards are quite the same as in the US and UK when it comes to shareholder interests versus that of management. I believe that as an investor one must have trust in the Company's management, but one reason for Trmor's low rating is the general lack of trust. Perhaps the Tremor management might take note of this and of our concerns and offer some money back by forfeiting their salaries for twelve months. But I won't hold my breath. I include the NED's, what are we paying them for.

So it might be safe in a small dosage. The question is, does it work and be effective against the cancer. No prizes for just falling short. I believe most investors will not be particularly impressed with yesterdays RNS, hence the lack of share price movement. Its like Amazon emailing you to say your order as been despatched when all you want to know is when it will arrive.

The problem with STC is the same as with all on line sales organisation, it is the cost of obtaining repeat customers, ie advertising . Continual expenditure on advertising is required. Where is the £m's annual spend coming from to keep sales flowing. There is competition out there and it is not as if STC is a household name.

Yes there is a £25m loan facility but this will not go very far spread over the number of ongoing projects.

I am not convinced d that cash will not become a problem here and I make my posts here in the hope that DV management will either dispel my and others concerns with a forecast for cash, not turnover or EBIT. Most small companies go under due lack of cash not turnover.

My big concern here is cash flow. Shareholders are in danger of being diluted out of existence. All the different businesses appear to be demanding cash. I can see a hugely discounted placing any time soon. This is, I believe what is holding the share price down.

Presumably these bottles will only be suitable for tablets and not liquids unless they have overcome the problem of degradation before being emptied.

I've been waiting since about 2013, not sure what's changed here. Always seems jam tomorrow with this share.

JOLLYSPECULATOR
Thanks, I missed Whipp selling 10% and another director selling 5%. Offset I suppose by three directors participating in the Placing to a somewhat limited extend. Not sure what conclusions can be drawn from the transactions as Whipp still has a huge shareholding.

Jollyspeculator
I see no recording of director sales at 3.0p. Large NED purchase @2.99p on 11 Oct 2021. Purchases were previously made on 23 April 2021 by various Directors. Please clarify.

Does anyone understand the trading update? For example what is meant by 'the deployment of investment capital led to slightly smaller losses for the year than the £700k expected at the EBIT and PBT levels.' Since this company has made increasing +ve PBT over the last three years and showed a PBT of £0.257K at the half way stage. Also under 'OUTLOOK' the RNS states '....our goal remains to reach EBITDA break even during 2022'. Yet they have been more than breaking even at EBITDA level for the past few years. F we take these statements at face value the implications are a large loss during the second half of the year or am I missing something. Anyone like to enlighten me.

Hellosandiego
One thing this company has done is spent decades losing shareholders money without proving anything. Now they are giving themselves millions more options for achieving nothing.

Now we know the reason for the late rise in SP yesterday. Trading based on inside information? AIM leaks like a sieve. Nevertheless good news.

Its not just about deaths, what about long Covid ! This government is still making mistakes, they just do not learn. Take mask wearing, a no brainer. Masks should be mandatory in all public places. This would not cost the economy anything. If you want proof of this just look at Japan and how they have reduced Covid infections since the completion of the Olympic Games. Their fully vaccination number is lower than the UK, the difference is mask wearing. No hindsight just common sense needed.

I do not think anyone on this BB disputes the utility of automatic waste water testing and monitoring. The real question is whether this can be achieved in practice and in a cost effective manner with the technology available at this time. Often what is achievable under laboratory conditions proves not possible in the real world environment. As far as I am concerned Dvrg as it all to prove in this respect. Until I see confirmed sales of this product I will continue to have reservations.

See latest RNS from Sabien and their involvement with oil from plastics. Must be direct competition with Powerhouse.

In NZ, waste water testing is being used successfully to track and identify cases in the current Covid outbreak. This is being done manually at sites all across the country, but obviously a possible future customer for Deepverge.

Looks as if someone is doing quite nicely out of Hardide. I wouldn't have thought ID.4 come cheap. I would have been more impressed if he'd spent the money on Hardide shares.

I am not sure that EBITDA is a good measure of performance with this company as I would expect depreciation to continue to be a high cost item.

Read the RNS, EBITDA2 will be around £115m, not profit. PRETAX more likely to be around £85m I suggest.